These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18343756)

  • 1. Characterization of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli from Posadas, Misiones, Argentina.
    Quiroga M; Caceres MG; Stefanuk R; Villalba V; Rodriguez MM; Radice M; Gutkind G; Vergara M
    J Chemother; 2008 Feb; 20(1):130-3. PubMed ID: 18343756
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
    Noguera O; López-Riquelme N; Rodríguez JC; Santibañez M; Alvarez L; Galiana A; Ruiz-García M; López-García P; Royo G
    Int J Antimicrob Agents; 2012 Aug; 40(2):189-90. PubMed ID: 22727771
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of screening methods for detection of extended-spectrum beta-lactamase producing strains isolated in Posadas, Misiones, Argentina.
    Quiroga M; Teresa Lezcano M; Gerula P; Valle M; Vergara M; Villalba V
    Int J Antimicrob Agents; 2002 Oct; 20(4):307-8. PubMed ID: 12385691
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
    Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
    J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the β-lactamases in Escherichia coli and Klebsiella pneumoniae from a tertiary care hospital in Riyadh, Saudi Arabia.
    Marie MA; John J; Krishnappa LG; Gopalkrishnan S
    Microbiol Immunol; 2013 Dec; 57(12):805-10. PubMed ID: 24117831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in Connecticut.
    Dandekar PK; Tetreault J; Quinn JP; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2004 May; 49(1):37-9. PubMed ID: 15135498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland.
    Forssten SD; Kolho E; Lauhio A; Lehtola L; Mero S; Oksaharju A; Jalava J; Tarkka E; Vaara M; Vuopio-Varkila J
    Clin Microbiol Infect; 2010 Aug; 16(8):1158-61. PubMed ID: 20670290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain.
    Hernández JR; Martínez-Martínez L; Cantón R; Coque TM; Pascual A;
    Antimicrob Agents Chemother; 2005 May; 49(5):2122-5. PubMed ID: 15855544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
    Cholley P; Thouverez M; Gbaguidi-Haore H; Sauget M; Slekovec C; Bertrand X; Talon D; Hocquet D
    Med Mal Infect; 2013 Aug; 43(8):331-6. PubMed ID: 23876202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
    Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
    J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
    Baykal A; Cöplü N; Simşek H; Esen B; Gür D
    Mikrobiyol Bul; 2012 Apr; 46(2):159-69. PubMed ID: 22639305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and detection of AmpC beta lactamases among clinical isolates of E. coli and K. pneumoniae causing UTI.
    Rajni E; Rawat U; Malhotra VL; Mehta G
    J Commun Dis; 2008 Mar; 40(1):21-5. PubMed ID: 19127665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B; Mehta S
    Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
    Markovska R; Schneider I; Keuleyan E; Bauernfeind A
    Clin Microbiol Infect; 2004 Aug; 10(8):752-5. PubMed ID: 15301679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
    FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
    Yu YS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1918-20. PubMed ID: 15631810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.